Bart Roelf Jan van Dijken (Bart R J van Dijken)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 10

Top Topics

Editorial Comment

End Stage Renal Disease

Top Venues

European radiology

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jesse D de Groot, Bart Roelf Jan van Dijken, Hiska L van der Weide, Roelien H Enting, Anouk van der Hoorn
Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients. PloS one 18 (5) (2023)
Jesse D de Groot, Bart Roelf Jan van Dijken, Hiska L van der Weide, Roelien H Enting, Anouk van der Hoorn
Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients. PloS one 18 (5) (2023)
Jesse D de Groot, Bart Roelf Jan van Dijken, Hiska L van der Weide, Roelien H Enting, Anouk van der Hoorn
Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients. PloS one 18 (5) (2023)
Jesse D de Groot, Bart Roelf Jan van Dijken, Hiska L van der Weide, Roelien H Enting, Anouk van der Hoorn
Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients. PloS one 18 (5) (2023)
Jesse D de Groot, Bart Roelf Jan van Dijken, Hiska L van der Weide, Roelien H Enting, Anouk van der Hoorn
Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients. PloS one 18 (5) (2023)
Bart Roelf Jan van Dijken, Hanne-Rinck Jeltema, Justyna Kłos, Peter Jan van Laar, Roelien H Enting, Ronald G H J Maatman, Klaas Bijsterveld, Wilfred F A Den Dunnen, Rudi A Dierckx, Paul E Sijens, Anouk van der Hoorn
The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma. Diagnostics (Basel, Switzerland) 13 (17) (2023)
Bart Roelf Jan van Dijken, Annerieke R Doff, Roelien H Enting, Peter Jan van Laar, Hanne-Rinck Jeltema, Rudi A J O Dierckx, Anouk van der Hoorn
Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More? Cancers 15 (20) (2023)
Bart Roelf Jan van Dijken, Alfred O Ankrah, Gilles N Stormezand, Rudi A J O Dierckx, Peter Jan van Laar, Anouk van der Hoorn
Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma. PloS one 17 (2) (2022)
Bart Roelf Jan van Dijken, A van der Hoorn
Radiology in the lead: towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation. European radiology 31 (3) (2021)
Bart Roelf Jan van Dijken, Bram Schuuring, Hanne-Rinck Jeltema, Peter Jan van Laar, Roelien H Enting, Rudi A J O Dierckx, Gilles N Stormezand, Anouk van der Hoorn
Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma. Neuroradiology (2021)